Kennan C Marsh - JoVE Visualize

Showing results (1-10 of 109) with videos related to

Pageof 11

Sort By:

ACS Medicinal Chemistry Letters|June 20, 2020

Assembling Pharma Resources to Tackle Diseases of Underserved PopulationsDale J Kempf, Kennan C Marsh

The Journal of Pharmacology and Experimental Therapeutics|January 4, 2008

Evoked changes in cardiovascular function in rats by infusion of levosimendan, OR-1896 [(R)-N-(4-(4-methyl-6-oxo-1,4,5,6-tetrahydropyridazin-3-yl)phenyl)acetamide], OR-1855 [(R)-6-(4-aminophenyl)-5-methyl-4,5-dihydropyridazin-3(2H)-one], dobutamine, and milrinone: comparative effects on peripheral resistance, cardiac output, dP/dt, pulse rate, and blood pressureJason A Segreti, Kennan C Marsh, James S Polakowski, et al.

Toxicology Letters|January 1, 2008

Evaluation of the effects of serial phlebotomy on the transcriptome of major tissues and on the response to toxicants in ratsEric A G Blomme, Rita Ciurlionis, Kennan C Marsh, et al.

Toxicology Letters|November 1, 2011

N-vinylpyrrolidone dimer, a novel formulation excipient, causes hepatic and thyroid hypertrophy through the induction of hepatic microsomal enzymes in ratsYi Yang, Rita Ciurlionis, Kenneth Kowalkowski, et al.

Drug Metabolism and Disposition: the Biological Fate of Chemicals|September 14, 2002

Implication of P450-metabolite complex formation in the nonlinear pharmacokinetics and metabolic fate of (+/-)-(1'R*,3R*)-3-phenyl-1-[(1',2',3',4'-tetrahydro-5',6'-methylene-dioxy-1'-naphthalenyl) methyl] pyrrolidine methanesulfonate (ABT-200) in dogsJames L Ferrero, Samuel B Thomas, Kennan C Marsh, et al.

Journal of Pharmaceutical Sciences|February 6, 2004

Ritonavir-PEG 8000 amorphous solid dispersions: in vitro and in vivo evaluationsDevalina Law, Eric A Schmitt, Kennan C Marsh, et al.

Bioorganic & Medicinal Chemistry Letters|August 15, 2009

Synthesis and evaluation of inhibitors of cytochrome P450 3A (CYP3A) for pharmacokinetic enhancement of drugsCharles A Flentge, John T Randolph, Peggy P Huang, et al.

Xenobiotica; the Fate of Foreign Compounds in Biological Systems|January 19, 2013

Species-dependent metabolism of a novel selective α7 neuronal acetylcholine receptor agonist ABT-107Hong Liu, Xiaoqing Deng, Jinrong Liu, et al.

British Journal of Clinical Pharmacology|October 19, 2023

Venetoclax pharmacokinetics in participants with end-stage renal disease undergoing haemodialysisBehnam Noorani, Rajeev M Menon, Xin Chen, et al.

Transplant International : Official Journal of the European Society for Organ Transplantation|January 22, 2004

Preliminary in vivo pharmacokinetic and pharmacodynamic evaluation of a novel calcineurin-independent inhibitor of NFATTudor Bîrsan, Camille Dambrin, Kennan C Marsh, et al.

Pageof 11

Showing results (1-10 of 109) with videos related to

Sort By:

Pageof 11

ACS Medicinal Chemistry Letters|June 20, 2020

Assembling Pharma Resources to Tackle Diseases of Underserved PopulationsDale J Kempf, Kennan C Marsh

The Journal of Pharmacology and Experimental Therapeutics|January 4, 2008

Evoked changes in cardiovascular function in rats by infusion of levosimendan, OR-1896 [(R)-N-(4-(4-methyl-6-oxo-1,4,5,6-tetrahydropyridazin-3-yl)phenyl)acetamide], OR-1855 [(R)-6-(4-aminophenyl)-5-methyl-4,5-dihydropyridazin-3(2H)-one], dobutamine, and milrinone: comparative effects on peripheral resistance, cardiac output, dP/dt, pulse rate, and blood pressureJason A Segreti, Kennan C Marsh, James S Polakowski, et al.

Toxicology Letters|January 1, 2008

Evaluation of the effects of serial phlebotomy on the transcriptome of major tissues and on the response to toxicants in ratsEric A G Blomme, Rita Ciurlionis, Kennan C Marsh, et al.

Toxicology Letters|November 1, 2011

N-vinylpyrrolidone dimer, a novel formulation excipient, causes hepatic and thyroid hypertrophy through the induction of hepatic microsomal enzymes in ratsYi Yang, Rita Ciurlionis, Kenneth Kowalkowski, et al.

Drug Metabolism and Disposition: the Biological Fate of Chemicals|September 14, 2002

Implication of P450-metabolite complex formation in the nonlinear pharmacokinetics and metabolic fate of (+/-)-(1'R*,3R*)-3-phenyl-1-[(1',2',3',4'-tetrahydro-5',6'-methylene-dioxy-1'-naphthalenyl) methyl] pyrrolidine methanesulfonate (ABT-200) in dogsJames L Ferrero, Samuel B Thomas, Kennan C Marsh, et al.

Journal of Pharmaceutical Sciences|February 6, 2004

Ritonavir-PEG 8000 amorphous solid dispersions: in vitro and in vivo evaluationsDevalina Law, Eric A Schmitt, Kennan C Marsh, et al.

Bioorganic & Medicinal Chemistry Letters|August 15, 2009

Synthesis and evaluation of inhibitors of cytochrome P450 3A (CYP3A) for pharmacokinetic enhancement of drugsCharles A Flentge, John T Randolph, Peggy P Huang, et al.

Xenobiotica; the Fate of Foreign Compounds in Biological Systems|January 19, 2013

Species-dependent metabolism of a novel selective α7 neuronal acetylcholine receptor agonist ABT-107Hong Liu, Xiaoqing Deng, Jinrong Liu, et al.

British Journal of Clinical Pharmacology|October 19, 2023

Venetoclax pharmacokinetics in participants with end-stage renal disease undergoing haemodialysisBehnam Noorani, Rajeev M Menon, Xin Chen, et al.

Transplant International : Official Journal of the European Society for Organ Transplantation|January 22, 2004

Preliminary in vivo pharmacokinetic and pharmacodynamic evaluation of a novel calcineurin-independent inhibitor of NFATTudor Bîrsan, Camille Dambrin, Kennan C Marsh, et al.

Pageof 11